• Patients
  • Healthcare Providers
  • Our Research Company ALITO AB

Potential to Replace Early Screening Methods for Diseases

Labio Medical focusing on developing a breath sampler ChromBreath™  that is standardised for several diseases under the AlitoBreasor medical concept . The AlitoBreasor analytical method concept, harmonizing the power of breath analysis, presents an invaluable paradigm shift in healthcare. Its potential reverberates across both healthcare providers and patients, ushering in a new era of diagnostics, personalized treatment, and patient-centered care.

Benefits for Patients

  1. Non-Invasive and Painless: The AlitoBreasor method eliminates the need for invasive procedures, offering patients a painless and comfortable diagnostic experience. This is particularly beneficial for individuals who may be averse to needles or uncomfortable tests.
  2. Early Detection and Prevention: Early disease detection is a cornerstone of the AlitoBreasor method. Patients benefit from timely identification of health issues, enabling proactive steps toward prevention and management, which ultimately improves their overall well-being.
  3. Personalized Care: Patients receive personalized care based on their unique molecular profiles. Treatment plans are tailored to their specific needs, optimizing efficacy and minimizing side effects.
  4. Convenience and Accessibility: The AlitoBreasor method opens avenues for convenient and accessible healthcare. Patients can undergo testing at various healthcare settings, reducing the need for extensive travel and facilitating routine monitoring.
  5. Reduced Healthcare Costs: By enabling early detection and preventive measures, the AlitoBreasor method has the potential to reduce long-term healthcare costs for patients. Timely interventions can mitigate the progression of diseases, minimizing expensive treatments.

Benefits for Healthcare Providers

  1. Swift and Precise Diagnostics: The AlitoBreasor method equips healthcare providers with a non-invasive, rapid, and accurate diagnostic tool. By analyzing breath samples, it offers insights into an individual’s physiological state, aiding in early disease detection and accurate diagnosis.
  2. Tailored Treatment Strategies: Armed with detailed molecular information obtained through breath analysis, healthcare providers can tailor treatment plans with exceptional precision. This targeted approach minimizes trial and error, optimizing therapeutic interventions and enhancing patient outcomes.
  3. Efficiency and Resource Optimization: The AlitoBreasor method streamlines diagnostic workflows. Healthcare providers can swiftly obtain critical information, facilitating quicker decision-making and reducing the need for invasive or time-consuming tests, thus optimizing resource utilization.

Focused Research through ALITO

Labio Medical AB’s subsidiary and affiliated company, ALITO AB, are identifying new research topics and involving cutting-edge medical research, specifically focused on the frontier of breath analysis. Through a collaborative synergy that brings together the expertise of both entities, and partner companies, a remarkable journey unfolds, ushering in a new era of diagnostics and healthcare innovation. The subsidiary’s expertise in identifying state-of-the-art technological platform solutions enables the realization of ALITO AB’s research findings into tangible solutions that can revolutionize medical diagnostics. Together, these entities spearhead initiatives that span a spectrum of medical disciplines. From identifying biomarkers indicative of diseases to pioneering non-invasive diagnostic tools, the collaboration catalyzes a holistic approach to understanding human health through the unique lens of breath analysis.